IT’S YOUR TIME TO IMAGINE
Student, artist, and actual Oxbryta patient
IT'S YOUR TIME
Mother, traveler, and actual Oxbryta patient
OXBRYTA is a prescription medicine used for the treatment of sickle cell disease in adults and children 4 years of age and older. It is not known if OXBRYTA is safe and effective in children with sickle cell disease below 4 years of age. OXBRYTA is approved under accelerated approval based on an increase in hemoglobin. Continued approval may depend on verification of clinical benefits in ongoing trials.
and her mother and caregiver Mapillar
reflect on how sickle cell has impacted Hajar’s life at home and school.
Sign up for virtual or local educational events to learn from a specialist about sickle
cell and how Oxbryta treats sickling at its source.
Actual Oxbryta patient